SG11201509856RA - Pharmaceutical preparation - Google Patents
Pharmaceutical preparationInfo
- Publication number
- SG11201509856RA SG11201509856RA SG11201509856RA SG11201509856RA SG11201509856RA SG 11201509856R A SG11201509856R A SG 11201509856RA SG 11201509856R A SG11201509856R A SG 11201509856RA SG 11201509856R A SG11201509856R A SG 11201509856RA SG 11201509856R A SG11201509856R A SG 11201509856RA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1075—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1051—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Extraction Or Liquid Replacement (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1310028.4A GB201310028D0 (en) | 2013-06-05 | 2013-06-05 | Pharmaceutical preparation |
PCT/EP2014/061743 WO2014195423A1 (en) | 2013-06-05 | 2014-06-05 | Pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201509856RA true SG11201509856RA (en) | 2015-12-30 |
Family
ID=48805787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201509856RA SG11201509856RA (en) | 2013-06-05 | 2014-06-05 | Pharmaceutical preparation |
Country Status (36)
Country | Link |
---|---|
US (2) | US20160114063A1 (sl) |
EP (1) | EP3003401B1 (sl) |
JP (1) | JP6580559B2 (sl) |
KR (1) | KR102321763B1 (sl) |
CN (1) | CN105592863B (sl) |
AP (1) | AP2015008894A0 (sl) |
AU (1) | AU2014276885B2 (sl) |
BR (1) | BR112015030298A2 (sl) |
CA (1) | CA2914278C (sl) |
CL (1) | CL2015003554A1 (sl) |
CR (1) | CR20150642A (sl) |
CU (1) | CU24535B1 (sl) |
DK (1) | DK3003401T3 (sl) |
DO (1) | DOP2015000294A (sl) |
EA (1) | EA201501174A1 (sl) |
ES (1) | ES2782624T3 (sl) |
GB (1) | GB201310028D0 (sl) |
HR (1) | HRP20200456T1 (sl) |
IL (1) | IL242704B (sl) |
LT (1) | LT3003401T (sl) |
MA (1) | MA38650B1 (sl) |
MX (1) | MX366028B (sl) |
MY (1) | MY180717A (sl) |
NI (1) | NI201500173A (sl) |
PE (1) | PE20160215A1 (sl) |
PH (1) | PH12015502715A1 (sl) |
PL (1) | PL3003401T3 (sl) |
PT (1) | PT3003401T (sl) |
RS (1) | RS60091B1 (sl) |
SA (1) | SA515370233B1 (sl) |
SG (1) | SG11201509856RA (sl) |
SI (1) | SI3003401T1 (sl) |
TN (1) | TN2015000527A1 (sl) |
UA (1) | UA120352C2 (sl) |
WO (1) | WO2014195423A1 (sl) |
ZA (1) | ZA201600027B (sl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201600158D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Purification method |
GB201600161D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope purification method |
WO2022157094A2 (en) | 2021-01-22 | 2022-07-28 | Bayer Aktiengesellschaft | Lrrc15 antibodies and conjugates thereof |
NO347755B1 (en) * | 2021-10-21 | 2024-03-18 | Blue Wave Therapeutics Gmbh | Peptide-coupled alginate gels comprising radionuclides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5749042A (en) * | 1997-01-28 | 1998-05-05 | Battelle Memorial Institute | Bismuth generator method |
GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
WO2010126979A1 (en) * | 2009-04-29 | 2010-11-04 | Bio-Rad Laboratories, Inc. | Purification of immunoconjugates |
GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
GB201105298D0 (en) * | 2011-03-29 | 2011-05-11 | Algeta Asa | Pharmaceutical preparation |
-
2013
- 2013-06-05 GB GBGB1310028.4A patent/GB201310028D0/en not_active Ceased
-
2014
- 2014-06-05 CN CN201480044621.8A patent/CN105592863B/zh active Active
- 2014-06-05 PL PL14728571T patent/PL3003401T3/pl unknown
- 2014-06-05 LT LTEP14728571.2T patent/LT3003401T/lt unknown
- 2014-06-05 CA CA2914278A patent/CA2914278C/en active Active
- 2014-06-05 SI SI201431535T patent/SI3003401T1/sl unknown
- 2014-06-05 RS RS20200349A patent/RS60091B1/sr unknown
- 2014-06-05 JP JP2016517608A patent/JP6580559B2/ja not_active Expired - Fee Related
- 2014-06-05 UA UAA201512920A patent/UA120352C2/uk unknown
- 2014-06-05 TN TN2015000527A patent/TN2015000527A1/en unknown
- 2014-06-05 CU CU2015000174A patent/CU24535B1/es unknown
- 2014-06-05 MA MA38650A patent/MA38650B1/fr unknown
- 2014-06-05 US US14/896,424 patent/US20160114063A1/en not_active Abandoned
- 2014-06-05 DK DK14728571.2T patent/DK3003401T3/da active
- 2014-06-05 WO PCT/EP2014/061743 patent/WO2014195423A1/en active Application Filing
- 2014-06-05 EA EA201501174A patent/EA201501174A1/ru unknown
- 2014-06-05 ES ES14728571T patent/ES2782624T3/es active Active
- 2014-06-05 PE PE2015002566A patent/PE20160215A1/es unknown
- 2014-06-05 AU AU2014276885A patent/AU2014276885B2/en active Active
- 2014-06-05 AP AP2015008894A patent/AP2015008894A0/xx unknown
- 2014-06-05 PT PT147285712T patent/PT3003401T/pt unknown
- 2014-06-05 MY MYPI2015704399A patent/MY180717A/en unknown
- 2014-06-05 MX MX2015016726A patent/MX366028B/es active IP Right Grant
- 2014-06-05 EP EP14728571.2A patent/EP3003401B1/en active Active
- 2014-06-05 SG SG11201509856RA patent/SG11201509856RA/en unknown
- 2014-06-05 KR KR1020157036893A patent/KR102321763B1/ko active IP Right Grant
- 2014-06-05 BR BR112015030298A patent/BR112015030298A2/pt active Search and Examination
-
2015
- 2015-11-22 IL IL242704A patent/IL242704B/en active IP Right Grant
- 2015-12-03 SA SA515370233A patent/SA515370233B1/ar unknown
- 2015-12-04 DO DO2015000294A patent/DOP2015000294A/es unknown
- 2015-12-04 CL CL2015003554A patent/CL2015003554A1/es unknown
- 2015-12-04 CR CR20150642A patent/CR20150642A/es unknown
- 2015-12-04 NI NI201500173A patent/NI201500173A/es unknown
- 2015-12-04 PH PH12015502715A patent/PH12015502715A1/en unknown
-
2016
- 2016-01-04 ZA ZA2016/00027A patent/ZA201600027B/en unknown
-
2020
- 2020-03-19 HR HRP20200456TT patent/HRP20200456T1/hr unknown
-
2021
- 2021-05-04 US US17/307,857 patent/US20220023449A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201905426B (en) | Drug combinations | |
PT3030262T (pt) | Composição farmacêutica de associação | |
GB201322602D0 (en) | Pharmaceutical compounds | |
GB201306610D0 (en) | Pharmaceutical compounds | |
ZA201602047B (en) | Pharmaceutical compounds | |
SG11201601477VA (en) | Pharmaceutical composition | |
SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
GB201318686D0 (en) | Pharmaceutical preparations | |
ZA201600027B (en) | Pharmaceutical preparation | |
GB201301721D0 (en) | Pharmaceutical Preparations | |
GB201312386D0 (en) | Pharmaceutical compounds | |
HK1220143A1 (zh) | 藥物組合物 | |
ZA201506465B (en) | Pharmaceutical preparation | |
GB201310496D0 (en) | Pharmaceutical combinations | |
GB201316662D0 (en) | Pharmaceutical Combination | |
GB201301723D0 (en) | Pharmaceutical combinations | |
GB201317166D0 (en) | Pharmaceutical compounds | |
GB201316780D0 (en) | Pharmaceutical compounds | |
GB201316791D0 (en) | Pharmaceutical Compounds | |
GB201315733D0 (en) | Pharmaceutical compounds | |
GB201315734D0 (en) | Pharmaceutical compounds | |
GB201312464D0 (en) | Pharmaceutical compounds | |
GB201308780D0 (en) | Pharmaceutical compounds | |
GB201308781D0 (en) | Pharmaceutical compounds | |
GB201308782D0 (en) | Pharmaceutical compounds |